The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 27, 2015
Filed:
Mar. 16, 2010
Applicants:
Jeffrey S. Glenn, Palo Alto, CA (US);
Wenjin Yang, Foster City, CA (US);
Ingrid C. Choong, Los Altos, CA (US);
Inventors:
Jeffrey S. Glenn, Palo Alto, CA (US);
Wenjin Yang, Foster City, CA (US);
Ingrid C. Choong, Los Altos, CA (US);
Assignee:
The Board of Trustees of the Leland Stanford Junior University, Palo Alto, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/56 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 491/08 (2006.01); C07K 14/005 (2006.01); A61K 31/416 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 38/21 (2006.01); A61K 31/55 (2006.01); A61K 31/454 (2006.01); A61K 31/7056 (2006.01); A61K 31/4439 (2006.01); A61K 31/506 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 31/416 (2013.01); A61K 31/5377 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); A61K 45/06 (2013.01); C07D 231/56 (2013.01); C12N 2770/24211 (2013.01); A61K 38/212 (2013.01); C07D 401/12 (2013.01); A61K 31/55 (2013.01); C07D 401/06 (2013.01); A61K 31/454 (2013.01); A61K 31/7056 (2013.01); C07D 405/14 (2013.01); A61K 31/4439 (2013.01); A61K 31/506 (2013.01); C07D 491/08 (2013.01); C12N 2770/24222 (2013.01); C07D 413/14 (2013.01); C12N 7/00 (2013.01);
Abstract
Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3'UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.